The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease

References

• Zhou TB, Qin YH, Lei FY, et al. Prohibitin attenuates oxidative stress and extracellular matrix accumulation in renal interstitial fibrosis disease. PLoS One 2013;8:e77187
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou Y, Guan Y. PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens 2012;21:97–105
   PubMed Web of Science ®Google Scholar
• Zhu C, Huang S, Yuan Y, et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARgamma. Am J Pathol 2011;178:2020–31
   PubMed Web of Science ®Google Scholar
• Correa-Costa M, Semedo P, Monteiro AP, et al. Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One 2010;5:e14298
   PubMed Web of Science ®Google Scholar
• Morisada N, Nomura M, Nishii H, et al. Complete disruption of all nitric oxide synthase genes causes markedly accelerated renal lesion formation following unilateral ureteral obstruction in mice in vivo. J Pharmacol Sci 2010;114:379–89
   PubMed Web of Science ®Google Scholar
• Okunuki Y, Usui Y, Nakagawa H, et al. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone suppresses experimental autoimmune uveitis. Exp Eye Res 2013;116:291–7
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Taniyama Y, Rakugi H, et al. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorgamma-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension. J Am Heart Assoc 2013;2:e000103
   Google Scholar
• Zhou TB, Drummen GP, Jiang ZP, et al. Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases. J Recept Signal Transduct Res 2013;33:349–52
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res 2013;33:28–36
   PubMed Web of Science ®Google Scholar
• Long YB, Qin YH, Zhou TB, et al. Association of retinoic acid receptors with extracellular matrix accumulation in rats with renal interstitial fibrosis disease. Int J Mol Sci 2012;13:14073–85
   PubMed Web of Science ®Google Scholar
• Hwang JS, Kang ES, Ham SA, et al. Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone inhibits lipopolysaccharide-induced release of high mobility group box 1. Mediators Inflamm 2012;2012:352807
   PubMedGoogle Scholar
• Ramer R, Heinemann K, Merkord J, et al. COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther 2013;12:69–82
   PubMed Web of Science ®Google Scholar
• Lin Q, Gu Y, Ma J, et al. Protection of rosiglitazone against renal interstitial lesion and its mechanism. Zhonghua Yi Xue Za Zhi 2005;85:1618–24
   PubMedGoogle Scholar
• Mino M, Nakamura J, Nakamuta N, et al. Effects of low protein intake on the development of the remaining kidney in subtotally nephrectomized immature rats: apoptosis and epidermal growth factor. J Vet Med Sci 2007;69:247–52
   PubMed Web of Science ®Google Scholar
• Radford MG Jr, Donadio JV Jr, Bergstralh EJ, et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199–207
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Lei FY, et al. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Exp Mol Pathol 2011;90:287–94
   PubMed Web of Science ®Google Scholar
• Sun D, Huang J, Zhang Z, et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One 2012;7:e33491
   PubMed Web of Science ®Google Scholar
• Djamali A, Vidyasagar A, Yagci G, et al. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation 2010;90:387–93
   PubMed Web of Science ®Google Scholar
• Kelley R, Werdin ES, Bruce AT, et al. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol 2010;299:F1026–39
   PubMed Web of Science ®Google Scholar
• Zhang P, Cai Y, Soofi A, et al. Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem 2012;287:21290–302
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun L, Xian W, et al. Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity. Lab Invest 2010;90:436–47
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang Y, Leander M, et al. Altered expression profile of renal alpha1D-adrenergic receptor in diabetes and its modulation by PPAR agonists. J Diabetes Res 2014;2014:725634
   Google Scholar
• Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm 2007;2007:62641
   PubMedGoogle Scholar
• Miana M, de Las Heras N, Rodriguez C, et al. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-gamma). J Physiol Pharmacol 2011;62:87–94
   PubMed Web of Science ®Google Scholar
• Kusunoki H, Taniyama Y, Azuma J, et al. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-gamma/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade. Hypertension 2012;59:308–16
   PubMed Web of Science ®Google Scholar
• Astapova O, Leff T. Adiponectin and PPARgamma: cooperative and interdependent actions of two key regulators of metabolism. Vitam Horm 2012;90:143–62
   PubMed Web of Science ®Google Scholar
• Sterlemann V, Rammes G, Wolf M, et al. Chronic social stress during adolescence induces cognitive impairment in aged mice. Hippocampus 2010;20:540–9
   PubMed Web of Science ®Google Scholar
• Sugii SE, vans RM. Epigenetic codes of PPARgamma in metabolic disease. FEBS Lett 2011;585:2121–8
   PubMed Web of Science ®Google Scholar
• Kamel-Reid S, Zhang T, Wells RA. Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis. Oncogene 2003;22:6424–35
   PubMed Web of Science ®Google Scholar
• Tabe Y, Konopleva M, Kondo Y, et al. PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL. Cancer Biol Ther 2007;6:1967–77
   PubMed Web of Science ®Google Scholar
• James SY, Lin F, Kolluri SK, et al. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. Cancer Res 2003;63:3531–8
   PubMed Web of Science ®Google Scholar